tiprankstipranks
Trending News
More News >
Annovis Bio (ANVS)
NYSE:ANVS
US Market

Annovis Bio (ANVS) Financial Statements

Compare
725 Followers

Annovis Bio Financial Overview

Annovis Bio's market cap is currently $73.72M. The company's EPS TTM is $-0.39; its P/E ratio is -2.46; Annovis Bio is scheduled to report earnings on March 16, 2026, and the estimated EPS forecast is $-0.40. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Mar 25Mar 24Mar 23Dec 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Income$ -29.70M$ -26.69M$ -45.03M$ -25.51M$ -14.54M
EBITDA$ -29.70M$ -26.69M$ -45.03M$ -25.51M$ -14.50M
Net Income$ -28.85M$ -24.59M$ -56.20M$ -25.33M$ -14.49M
Balance Sheet
Cash & Short-Term Investments$ 19.53B$ 10.55M$ 5.75M$ 28.38M$ 45.69M
Total Assets$ 21.08B$ 13.93M$ 10.21M$ 36.02M$ 46.00M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -19.53B$ -10.55M$ -5.75M$ -28.38M$ -45.69M
Total Liabilities$ 4.23B$ 4.62M$ 17.96M$ 7.70M$ 1.51M
Stockholders' Equity$ 16.85B$ 9.31M$ -7.75M$ 28.32M$ 44.49M
Cash Flow
Free Cash Flow$ -25.62B$ -21.89B$ -39.97M$ -17.31M$ -9.13M
Operating Cash Flow$ -25.62B$ -21.89B$ -39.97M$ -17.31M$ -9.13M
Investing Cash Flow$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Financing Cash Flow$ 34.60B$ 26.69B$ 17.34M$ 4.61K$ 46.74M
Currency in USD

Annovis Bio Earnings and Revenue History

Annovis Bio Debt to Assets

Annovis Bio Cash Flow

Annovis Bio Forecast EPS vs Actual EPS